_version_ 1784831996059451392
author Barbui, Tiziano
Ghirardi, Arianna
Carobbio, Alessandra
Masciulli, Arianna
Carioli, Greta
Rambaldi, Alessandro
Finazzi, Maria Chiara
Bellini, Marta
Rumi, Elisa
Vanni, Daniele
Borsani, Oscar
Passamonti, Francesco
Mora, Barbara
Brociner, Marco
Guglielmelli, Paola
Paoli, Chiara
Alvarez-Larran, Alberto
Triguero, Ana
Garrote, Marta
Pettersson, Helna
Andréasson, Björn
Barosi, Giovanni
Vannucchi, Alessandro Maria
author_facet Barbui, Tiziano
Ghirardi, Arianna
Carobbio, Alessandra
Masciulli, Arianna
Carioli, Greta
Rambaldi, Alessandro
Finazzi, Maria Chiara
Bellini, Marta
Rumi, Elisa
Vanni, Daniele
Borsani, Oscar
Passamonti, Francesco
Mora, Barbara
Brociner, Marco
Guglielmelli, Paola
Paoli, Chiara
Alvarez-Larran, Alberto
Triguero, Ana
Garrote, Marta
Pettersson, Helna
Andréasson, Björn
Barosi, Giovanni
Vannucchi, Alessandro Maria
author_sort Barbui, Tiziano
collection PubMed
description
format Online
Article
Text
id pubmed-9668822
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-96688222022-11-18 Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score Barbui, Tiziano Ghirardi, Arianna Carobbio, Alessandra Masciulli, Arianna Carioli, Greta Rambaldi, Alessandro Finazzi, Maria Chiara Bellini, Marta Rumi, Elisa Vanni, Daniele Borsani, Oscar Passamonti, Francesco Mora, Barbara Brociner, Marco Guglielmelli, Paola Paoli, Chiara Alvarez-Larran, Alberto Triguero, Ana Garrote, Marta Pettersson, Helna Andréasson, Björn Barosi, Giovanni Vannucchi, Alessandro Maria Blood Cancer J Correspondence Nature Publishing Group UK 2022-11-16 /pmc/articles/PMC9668822/ /pubmed/36385103 http://dx.doi.org/10.1038/s41408-022-00743-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correspondence
Barbui, Tiziano
Ghirardi, Arianna
Carobbio, Alessandra
Masciulli, Arianna
Carioli, Greta
Rambaldi, Alessandro
Finazzi, Maria Chiara
Bellini, Marta
Rumi, Elisa
Vanni, Daniele
Borsani, Oscar
Passamonti, Francesco
Mora, Barbara
Brociner, Marco
Guglielmelli, Paola
Paoli, Chiara
Alvarez-Larran, Alberto
Triguero, Ana
Garrote, Marta
Pettersson, Helna
Andréasson, Björn
Barosi, Giovanni
Vannucchi, Alessandro Maria
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title_full Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title_fullStr Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title_full_unstemmed Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title_short Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score
title_sort increased risk of thrombosis in jak2 v617f-positive patients with primary myelofibrosis and interaction of the mutation with the ipss score
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9668822/
https://www.ncbi.nlm.nih.gov/pubmed/36385103
http://dx.doi.org/10.1038/s41408-022-00743-0
work_keys_str_mv AT barbuitiziano increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT ghirardiarianna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT carobbioalessandra increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT masciulliarianna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT carioligreta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT rambaldialessandro increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT finazzimariachiara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT bellinimarta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT rumielisa increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT vannidaniele increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT borsanioscar increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT passamontifrancesco increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT morabarbara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT brocinermarco increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT guglielmellipaola increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT paolichiara increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT alvarezlarranalberto increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT trigueroana increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT garrotemarta increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT petterssonhelna increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT andreassonbjorn increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT barosigiovanni increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore
AT vannucchialessandromaria increasedriskofthrombosisinjak2v617fpositivepatientswithprimarymyelofibrosisandinteractionofthemutationwiththeipssscore